← Back to S&P 500 Dashboard

RVTY

SELL

Revvity, Inc.

Healthcare · Rank #338 · Analyzed Apr 20, 2026

$93.96

Current Price

$41.28

Intrinsic Value

-23.1%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree
Quality Score2/5.0
Framework RatingSELL
Price vs Intrinsic ValueOvervalued by 23.1%

Fair Value Range

Low$17.07
Base (IV)$41.28
High$72.27

Entry Points

Conservative$17.07
Moderate$29.17
Aggressive$41.28

Quality & Moat Breakdown

Return on Equity3.2% → 0/1.0
Debt LevelD/E 47 → 0.5/1.0
Revenue QualityGrowth 6.1%, margin Δ-5.2% +recovery → 1.0/1.0
Moat Strength2.0/5 → 0/1.0
Profit Margins8.4% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.